| ANI PHARMACEUT. DL-,0001 |
| USA |
| Gesundheit |
| US00182C1036 / A1W15D |
| BSFA (Frankfurt) / ANIP (NASDAQ) |
| FRA:BSFA, ETR:BSFA, BSFA:GR, NASDAQ:ANIP |
| - |
| https://anipharmaceutical.. |
|
ANI Pharmaceuticals, Inc. is a biopharmaceutical company that develops, manufactures, and commercializes branded, generic, and specialty prescription medicines. ANI Pharmaceuticals focuses on three main areas: Rare Disease, Generics, and Established ..
>Volltext.. |
| 1477.38 Mio. EUR |
| 1684.42 Mio. EUR |
| 878.24 Mio. EUR |
| 194.17 Mio. EUR |
| 89.72 Mio. EUR |
| 4.32 EUR |
| 548.01 Mio. EUR |
| 323.38 Mio. EUR |
| 170.07 Mio. EUR |
| 1.33 |
| 35.02% |
| - |
| - |
| - |
| - |
| ANI PHARMA, ANI PHARMACEUTICALS |
| 09.11.26 |
|
||||
|